11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing’s disease

Background Symptoms of hyperandrogenism are common in patients with Cushing’s disease (CD), yet they are not sufficiently explained by androgen concentrations. In this study, we analyzed the contribution of 11-oxygenated C19 steroids (11oxC19) to hyperandrogenemia in female patients with CD. Methods We assessed saliva day profiles in females with CD pre (n  = 23) and post (n  = 13) successful transsphenoidal surgery, 26 female controls, 5 females with CD treated with metyrapone and 5 treated with osilodrostat for cortisol, cortisone, androstenedione (A4), 11-hydroxyandrostenedione (11OHA4), testosterone (TS), 11-ketotestosterone (11KT), as well as metabolites of classic and 11-oxygenated androgens in 24-h urine. In addition, morning baseline levels of gonadotropins and estradiol, sex hormone-binding globulin, cortisol and dehydroepiandrosterone sulfate (DHEAS) in serum and adrenocorticotrophic hormone in plasma in patients and controls were investigated. Results Treatment-naïve females with CD showed a significantly elevated area under the curve of 11OHA4 and 11KT in saliva throughout the day compared to controls (11OHA4 mean rank difference (mrd) 18.13, P = 0.0002; 11KT mrd 17.42; P = 0.0005), whereas A4, TS and DHEAS were comparable to controls. Gonadotropin concentrations were normal in all patients with CD. After transsphenoidal surgery, 11oxC19 and their metabolites dropped significantly in saliva (11OHA4 P < 0.0001; 11KT P = 0.0010) and urine (11-oxo-androsterone P = 0.0011; 11-hydroxy-androsterone P < 0.0001), treatment with osilodrostat and metyrapone efficaciously blocked 11oxC19 synthesis. Conclusion Hyperandrogenemia in CD is predominantly caused by excess of 11oxC19 steroids.

• Publication year

  2022

• Venue

  European Journal of Endocrinology

• Publication date

  2022-05-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/EJE-22-0320PMID 36074938PMCID 9578081
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-Dependent Cushing Syndrome Patients.

  2022cited by this paper
• Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia

  2021cited by this paper
• Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a doubleblind, randomised withdrawal phase.

  2020cited by this paper
• Recurrence after pituitary surgery in adult Cushing’s disease: a systematic review on diagnosis and treatment

  2020cited by this paper
• Urinary GC-MS Steroid Metabotyping in treated Children with Congenital Adrenal Hyperplasia.

  2020cited by this paper
• 11-Oxygenated Estrogens Are a Novel Class of Human Estrogens but Do not Contribute to the Circulating Estrogen Pool

  2020cited by this paper
• Androgens in Cushing's Syndrome.

  2019influential reference
• A liquid chromatography-tandem mass spectrometry assay for the profiling of classical and 11-oxygenated androgens in saliva

  2019cited by this paper
• Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.

  2019influential reference
• Serum steroid profiling in Cushing's syndrome patients.

  2019cited by this paper
• Characterizing the steroidal milieu in amniotic fluid of mid-gestation: A GC-MS study.

  2019cited by this paper
• Measurement of salivary adrenal-specific androgens as biomarkers of therapy control in 21-hydroxylase deficiency.

  2019cited by this paper
• Salivary Cortisone to Estimate Cortisol Exposure and Sampling Frequency Required Based on Serum Cortisol Measurements

  2018cited by this paper
• Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome.

  2018cited by this paper
• Clinical significance of 11-oxygenated androgens

  2017cited by this paper
• Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency.

  2016influential reference
• Steroid Metabolomic Disease Signature of Nonsyndromic Childhood Obesity.

  2016cited by this paper
• 11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored

  2016influential reference
• Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease

  2015cited by this paper
• The Treatment of Cushing's Disease.

  2015cited by this paper
• Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

  2015cited by this paper
• Cushing's syndrome.

  2015cited by this paper
• LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study.

  2014cited by this paper
• Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation.

  2013cited by this paper
• Cushing's Syndrome.

  2008cited by this paper
• The diagnosis and differential diagnosis of endogenous Cushing's syndrome.

  2006cited by this paper
• Cushing's syndrome.

  2001cited by this paper
• Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.

  2001cited by this paper
• Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome

  1994cited by this paper
• Short and long‐term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome

  1991cited by this paper
• Adrenal cysts: diagnosis and management.

  1990cited by this paper
• GONADOTROPHIN LEVELS IN WOMEN WITH CUSHING'S SYNDROME BEFORE AND AFTER TREATMENT

  1981cited by this paper
• [Treatment of Cushing's disease].

  1978cited by this paper
• Adrenal cysts. Diagnosis and management.

  1974cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Menstrual Abnormalities in Women with Cushing’s Disease Are Correlated with Hypercortisolemia Rather Than Raised Circulating Androgen Levels

  year unknowncited by this paper

• Sex steroids, SHBG and type 2 diabetes in women: what do we really know?

  2026cites this paper
• Current insights into monitoring of congenital adrenal hyperplasia.

  2026cites this paper
• Adolescent hyperandrogenism: diagnostic challenges and therapeutic approaches

  2025cites this paper
• Salivary Testosterone, Androstenedione and 11‐Oxygenated 19‐Carbon Concentrations Differ by Age and Sex in Children

  2025cites this paper
• Adrenal steroids: New assays, new methods.

  2025cites this paper
• Metabolomics studies in cushing’s syndrome: recent developments and perspectives

  2025cites this paper
• Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations

  2025cites this paper
• Osilodrostat-associated Adrenal Gland Shrinkage: a Case Series of Patients with ACTH-Dependent Cushing's Syndrome.

  2025cites this paper
• Medical treatment of functional pituitary adenomas, trials and tribulations

  2024cites this paper
• Medical Therapy of Endogenous Cushing’s Syndrome with Steroidogenesis Inhibitors: Treatment Rationale, Available Drugs, and Therapeutic Effects

  2024cites this paper
• Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease

  2024cites this paper
• Cushing's Syndrome in the Elderly

  2024cites this paper
• The Landscape of Androgens in Cushing’s Syndrome

  2024influential citation
• Plasma Steroid Profiling Between Patients With and Without Diabetes Mellitus in Nonfunctioning Adrenal Incidentalomas

  2024cites this paper
• The interpretation of immunometric, chromatographic and mass spectrometric data for steroids in diagnosis of endocrine disorders.

  2024cites this paper
• Prevalence of adrenal rest tumors and course of gonadal dysfunction in a clinical sample of men with congenital adrenal hyperplasia - a longitudinal analysis over 10 years.

  2024cites this paper
• Alternative androgen pathways

  2023cites this paper
• Inhibition of the glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excess

  2023cites this paper
• Circulating adrenal 11-oxygenated androgens are associated with clinical outcome in endometrial cancer

  2023cites this paper
• The clinical and biochemical significance of 11-oxygenated androgens in human health and disease.

  2023cites this paper
• Delineating endogenous Cushing’s syndrome by GC-MS urinary steroid metabotyping

  2023cites this paper
• An individualized approach to the management of Cushing disease

  2023cites this paper
• Cushing’s syndrome in women: age-related differences in etiology and clinical picture

  2022cites this paper
• 11-Oxygenated androgens are not secreted by the human ovary: in-vivo data from four different cases of hyperandrogenism

  2022cites this paper
• WikiJournal Preprints/Alternative androgen pathways

  year unknowncites this paper